Difference between revisions of "Chidamide (Epidaza)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
m |
||
Line 1: | Line 1: | ||
==Mechanism of action== | ==Mechanism of action== | ||
− | HDAC | + | From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucidinostat NCI Drug Dictionary]: An orally bioavailable benzamide type inhibitor of histone deacetylase (HDAC) isoenzymes 1, 2, 3 and 10, with potential antineoplastic activity. Tucidinostat selectively binds to and inhibits HDAC leading to an increase of acetylation levels of histone protein H3. This agent also inhibits the expression of signaling kinases in the PI3K/Akt and MAPK/Ras signaling pathways and may result in cell cycle arrest and the induction of tumor cell apoptosis. This may inhibit tumor cell proliferation in susceptible tumor cells. |
− | == | + | ==Diseases for which it is used== |
− | + | *[[Peripheral T-cell lymphoma]] | |
− | |||
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
Line 10: | Line 9: | ||
==Also known as== | ==Also known as== | ||
− | *'''Code | + | *'''Code names:''' CS055, HBI-8000 |
+ | *'''Generic name:''' tucidinostat | ||
*'''Brand name:''' Epidaza | *'''Brand name:''' Epidaza | ||
Revision as of 21:52, 11 August 2018
Mechanism of action
From the NCI Drug Dictionary: An orally bioavailable benzamide type inhibitor of histone deacetylase (HDAC) isoenzymes 1, 2, 3 and 10, with potential antineoplastic activity. Tucidinostat selectively binds to and inhibits HDAC leading to an increase of acetylation levels of histone protein H3. This agent also inhibits the expression of signaling kinases in the PI3K/Akt and MAPK/Ras signaling pathways and may result in cell cycle arrest and the induction of tumor cell apoptosis. This may inhibit tumor cell proliferation in susceptible tumor cells.
Diseases for which it is used
History of changes in FDA indication
Not FDA approved, but is approved for use in China.
Also known as
- Code names: CS055, HBI-8000
- Generic name: tucidinostat
- Brand name: Epidaza